Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SSY
3176
DELISTED
SunLink Health Systems
SSY
| $159K | ﹤0.01% |
139,200
+2,500
| +2% | +$2.94K |
|
3177
The ONE Group
STKS
$56.5M
| $157K | ﹤0.01% |
51,200
-19,700
| -28% | -$58.9K |
|
|
ATXS
3178
DELISTED
Astria Therapeutics
ATXS
| $156K | ﹤0.01% |
5,953
-1,609
| -21% | -$60.9K |
|
3179
SiNtx Technologies
SINT
$9.98M
| $156K | ﹤0.01% |
1
| – | – |
|
3180
Soligenix
SNGX
$8.29M
| $156K | ﹤0.01% |
756
+338
| +81% | +$95.2K |
|
|
SVBI
3181
DELISTED
Severn Bancorp Inc/MD
SVBI
| $155K | ﹤0.01% |
19,400
-8,200
| -30% | -$70.3K |
|
|
AFMD
3182
DELISTED
Affimed
AFMD
| $153K | ﹤0.01% |
4,907
-1,043
| -18% | -$38.8K |
|
|
RGLS
3183
DELISTED
Regulus Therapeutics
RGLS
| $149K | ﹤0.01% |
16,007
+11,044
| +223% | +$183K |
|
|
JP
3184
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
| $149K | ﹤0.01% |
33,900
-191,000
| -85% | -$1.38M |
|
3185
Ocugen
OCGN
$475M
| $145K | ﹤0.01% |
27,374
+21,107
| +337% | +$673K |
|
|
AVGR
3186
DELISTED
Avinger, Inc. Common Stock
AVGR
| $143K | ﹤0.01% |
159
+118
| +288% | +$196K |
|
|
NOVN
3187
DELISTED
Novan, Inc. Common Stock
NOVN
| $142K | ﹤0.01% |
17,104
+8,134
| +91% | +$166K |
|
3188
Destination XL Group
DXLG
$33M
| $141K | ﹤0.01% |
65,000
+48,600
| +296% | +$130K |
|
3189
Danaos Corp
DAC
$2.55B
| $140K | ﹤0.01% |
13,339
-6,970
| -34% | -$100K |
|
3190
Euroseas
ESEA
$525M
| $140K | ﹤0.01% |
30,685
+14,309
| +87% | +$115K |
|
3191
Fortress Biotech
FBIO
$91.4M
| $140K | ﹤0.01% |
10,850
-14,365
| -57% | -$240K |
|
|
SNCR
3192
DELISTED
Synchronoss Technologies
SNCR
| $140K | ﹤0.01% |
+2,532
| New | +$139K |
|
|
ACCS
3193
ACCESS Newswire
ACCS
$20M
| $140K | ﹤0.01% |
12,300
-9,373
| -43% | -$119K |
|
|
CBL
3194
DELISTED
CBL& Associates Properties, Inc.
CBL
| $137K | ﹤0.01% |
+71,300
| New | +$209K |
|
3195
Sonoma Pharmaceuticals
SNOA
$6.56M
| $134K | ﹤0.01% |
1,046
+357
| +52% | +$71.2K |
|
3196
Ovid Therapeutics
OVID
$489M
| $133K | ﹤0.01% |
+55,100
| New | +$251K |
|
3197
SCYNEXIS
SCYX
$47.9M
| $130K | ﹤0.01% |
3,378
+2,816
| +501% | +$191K |
|
|
ABAC
3198
DELISTED
Renmin Tianli Group, Inc. Common Shares
ABAC
| $130K | ﹤0.01% |
149,817
+6,600
| +5% | +$10.2K |
|
3199
Better Online Solutions
BOSC
$31.8M
| $129K | ﹤0.01% |
59,329
-21,663
| -27% | -$48.4K |
|
3200
China Pharma Holdings
CPHI
$44.2M
| $129K | ﹤0.01% |
1,001
+19
| +2% | +$2.76K |
|
Similar funds
Jim Simons's Q4 2018 Portfolio in Review
As of Q4 2018, Jim Simons held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Jim Simons's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Jim Simons's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Jim Simons fully exited Danaher in Q4 2018, selling an estimated $350M.
- Jim Simons's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Jim Simons opened 522 new positions and closed 504 in Q4 2018.
- Jim Simons's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.